Published in Gastroenterology on September 01, 1993
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
Coeliac disease in primary care: case finding study. BMJ (1999) 3.60
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A (2004) 2.33
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut (1995) 2.29
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell (2016) 1.89
Increasing incidence of celiac disease in a North American population. Am J Gastroenterol (2013) 1.69
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int (2008) 1.62
Celiac disease and autoimmune endocrinologic disorders. Dig Dis Sci (1999) 1.58
Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients. Dig Dis Sci (2012) 1.45
Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort. Clin Gastroenterol Hepatol (2015) 1.44
Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci (2003) 1.41
Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet (2009) 1.39
Redox regulation of transglutaminase 2 activity. J Biol Chem (2010) 1.38
Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr (2008) 1.24
Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet (1999) 1.20
Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease. Gut (2000) 1.15
Genome search in celiac disease. Am J Hum Genet (1998) 1.14
The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10
Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol (2001) 1.09
Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus. Gut (1995) 1.07
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics (2009) 1.05
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations. J Immunol (2011) 1.04
Celiac disease: diagnostic criteria in progress. Cell Mol Immunol (2011) 1.04
FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut (2001) 1.03
HLA and disease. Eur J Epidemiol (2005) 1.00
Prevalence of coeliac disease in children and adolescents with type 1 diabetes mellitus in a clinic based population. Postgrad Med J (2007) 0.98
Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin. J Am Chem Soc (2006) 0.97
Gluten: a two-edged sword. Immunopathogenesis of celiac disease. Springer Semin Immunopathol (2005) 0.95
Celiac disease in the elderly. Gastroenterol Clin North Am (2009) 0.95
Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci. PLoS One (2012) 0.93
Clinical practice : coeliac disease. Eur J Pediatr (2012) 0.92
Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients. World J Gastroenterol (2014) 0.91
Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life. J Clin Invest (2001) 0.90
Coeliac disease and liver dysfunction. Arch Dis Child (2002) 0.90
Influence of infant feeding and gluten intake on coeliac disease. Arch Dis Child (1997) 0.89
Changing jejunal gamma delta T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease. Clin Exp Immunol (1999) 0.88
A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A (1996) 0.88
Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease. Bioorg Med Chem (2007) 0.87
Binding of gluten-derived peptides to the HLA-DQ2 (alpha1*0501, beta1*0201) molecule, assessed in a cellular assay. Clin Exp Immunol (1998) 0.87
Serological assessment for celiac disease in IgA deficient adults. PLoS One (2014) 0.85
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. Clin Transl Gastroenterol (2012) 0.85
Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population. World J Gastroenterol (2005) 0.84
Coeliac disease in children of West Indian origin. Arch Dis Child (1995) 0.83
Assessing of Celiac Disease and Nonceliac Gluten Sensitivity. Gastroenterol Res Pract (2015) 0.83
Celiac disease and HLA in a Bedouin kindred. Hum Immunol (2006) 0.82
Sarcoidosis in patients with celiac disease. Dig Dis Sci (2007) 0.80
Dermatomyositis associated with celiac disease: response to a gluten-free diet. Can J Gastroenterol (2006) 0.80
Pathogenesis of coeliac disease: implications for treatment. World J Gastroenterol (2001) 0.79
New automated immunoassay measuring immunoglobulin A antigliadin antibodies for prediction of celiac disease in childhood. Clin Diagn Lab Immunol (2001) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
Celiac disease and immigration in Northeastern Italy: the "drawn double nostalgia" of "cozonac" and "panettone" slices. Clin Exp Gastroenterol (2011) 0.78
Intestinal proliferation in coeliac disease: looking into the crypt. Gut (1995) 0.78
Candidate gene regions and genetic heterogeneity in gluten sensitivity. Gut (2001) 0.78
Relative power of linkage and transmission disequilibrium test strategies to detect non-HLA linked coeliac disease susceptibility genes. Gut (1999) 0.78
Linkage analysis of HLA and candidate genes for celiac disease in a North American family-based study. BMC Med Genet (2001) 0.77
Dietary modifications: food dependent autoimmunity in coeliac disease. Gut (1998) 0.77
Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Dig Dis Sci (2004) 0.77
Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies. World J Gastroenterol (2006) 0.76
Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus (2010) 0.76
Hypogalactosylation of serum IgG in patients with coeliac disease. Clin Exp Immunol (2003) 0.76
Circulating T lymphocyte subsets in coeliac disease (CoD) patients and healthy family members. Clin Exp Immunol (1998) 0.76
Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications. Nutrients (2015) 0.75
The changing face of celiac disease. Paediatr Child Health (2001) 0.75
Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Sci Rep (2016) 0.75
The seroprevalence of immunoglobulin A transglutaminase in type 1 diabetic patients of South Indian origin. Indian J Endocrinol Metab (2016) 0.75
Stereotyped antibody responses target posttranslationally modified gluten in celiac disease. JCI Insight (2017) 0.75
Distribution of HLA class I alleles differs in celiac disease patients according to age of onset. Dig Dis Sci (2003) 0.75
Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl. Rheumatol Int (2009) 0.75
Clinical and genetic profile of patients with seronegative coeliac disease: the natural history and response to gluten-free diet. BMJ Open Gastroenterol (2017) 0.75
Increased prevalence of celiac disease in patients with oral lichen planus. Clin Oral Investig (2014) 0.75
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera. Scand J Immunol (1978) 2.70
HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17
Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09
[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02
HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85
Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol (1977) 1.84
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev (1982) 1.51
The human mixed lymphocyte-endothelium culture interaction. Transplantation (1975) 1.50
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45
Antigen-presenting properties of human vascular endothelial cells. J Exp Med (1980) 1.43
Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43
HLA-D region molecules restrict proliferative T cell responses to antigen. Immunol Rev (1982) 1.42
The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region. J Exp Med (1977) 1.38
Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods (1986) 1.38
T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27
The human major histocompatibility system. Transplant Rev (1974) 1.25
Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes (1997) 1.22
A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens (1999) 1.22
HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. Tissue Antigens (1971) 1.22
Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22
The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis (1983) 1.21
Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19
Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun (2003) 1.19
Cell specific and common antigens on human granulocytes and lymphocytes demonstrated with cytotoxic hetero-antibodies. Vox Sang (1967) 1.19
HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol (1992) 1.17
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet (1995) 1.17
Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology (1997) 1.17
Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera. Transplant Proc (1979) 1.17
Rga (Rodgers) and the HLA region: linkage and associations. Tissue Antigens (1976) 1.16
Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand J Immunol (1987) 1.15
HLA DR antigens and gold toxicity. Ann Rheum Dis (1983) 1.14
Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol (1990) 1.12
Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens (1997) 1.11
Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens (1991) 1.11
Cell mediated lympholysis: CML. a microplate technique requiring few target cells and employing a new method of supernatant collection. J Immunol Methods (1977) 1.10
Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol (1981) 1.10
T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1989) 1.09
Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. Acta Derm Venereol (1980) 1.09
The Bf locus in the HLA region of chromosome 6: linkage and association studies. Humangenetik (1975) 1.07
T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol (1994) 1.07
HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.06
Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol (1997) 1.06
HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum (1983) 1.05
HLA-D region products are expressed in endothelial cells. Tissue Antigens (1980) 1.03
Polymorphism of the HL-A system. Transplant Proc (1971) 1.03
Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics (1996) 1.02
In vitro sensitization of human T lymphocytes to hapten (TNP)-conjugated and non-treated autologous cells is restricted by self-HLA-D. Scand J Immunol (1979) 1.02
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens (1990) 1.01
Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am J Hum Genet (1998) 1.01
Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6). Hum Mol Genet (1998) 1.01
Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum Mol Genet (1997) 1.01
Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells. J Virol Methods (1989) 1.01
Further evidence of a third HL-A locus. Tissue Antigens (1973) 1.00
Activation of human suppressor cells in mixed lymphocyte cultures. Scand J Immunol (1977) 1.00
HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet (2001) 1.00
C3 polymorphism: genetic linkage relations. Clin Genet (1974) 1.00
The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum Immunol (1989) 0.99
HLA-D-restricted antigen activation of sensitized T lymphocytes: studies on the ability of HLA-D/DR-expressing B lymphocytes to substitute for macrophages in antigen activation. Scand J Immunol (1979) 0.99
On the orientation of the HL-A region and the PGM3 locus in the chromosome. Tissue Antigens (1972) 0.99
Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun (2009) 0.98
Antigen-specific proliferative human T-lymphocyte clones with specificity for Chlamydia trachomatis. Scand J Immunol (1983) 0.98
Beta-2-microglobulin is part of the HL-A molecule in the lymphocyte membrane. Nature (1974) 0.98
CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (Gly13-->Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation. Cancer Immunol Immunother (1995) 0.98
Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. Hum Immunol (1984) 0.97
Enriched epidermal Langerhans cells are potent antigen-presenting cells for T cells. J Invest Dermatol (1984) 0.97
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens (2007) 0.97
Mixed lymphocyte cultures and HL-A identity in unrelated subjects. Nature (1970) 0.97
The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens (2007) 0.97
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun (2007) 0.96
Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol (1997) 0.96
Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol (1994) 0.96
HLA-DQw3.1 and DQw3.2 associated exon polymorphisms detected by oligonucleotide probes. Tissue Antigens (1988) 0.96
Serologic recognition of HLA-D-associated determinants. Transplant Proc (1977) 0.96
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study. Int J Cancer (1996) 0.95
Presence of HLA-D determinants on human macrophages. Nature (1976) 0.95
T-cell clones with similar antigen specificity may be restricted by DR, MT(DC), or SB class II HLA molecules. Immunogenetics (1984) 0.95
Antigens on human fibroblasts demonstrated with HL-A antisera and anti-human lymphocytic sera. Vox Sang (1968) 0.95